US Patent 7683040 Intranasal formulation of rotigotine
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and α-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5-1.5 mm2/s.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07683040 Intranasal formulation of rotigotine US Patent 7683040 Intranasal formulation of rotigotine
Infobox
Patent Number
0768304000
Patent Number
768304000
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076830400
Date of Patent
March 23, 2010
0Patent Application Number
105455300
Date Filed
December 22, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076830400
Date of Patent
March 23, 2010
0Patent Application Number
105455300
Date Filed
December 22, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07683040 Intranasal formulation of rotigotine
Infobox
Is a
Patent jurisdiction
Patent number
07683040
Date of patent
March 23, 2010
Patent application number
10545530
Date Filed
December 22, 2004
Patent primary examiner
Find more entities like US Patent 7683040 Intranasal formulation of rotigotine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
